Phase I Study of Local Radiation and CP-675,206 Administration in Patients With Inoperable Locally Recurrent or Metastatic Breast Cancer

Trial Profile

Phase I Study of Local Radiation and CP-675,206 Administration in Patients With Inoperable Locally Recurrent or Metastatic Breast Cancer

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2015

At a glance

  • Drugs Tremelimumab (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 15 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top